Research and Markets (http://www.researchandmarkets.com/research/9tcnnj/optic) has announced the addition of the "Optic Neuritis-Pipeline Insights, 2015" subscription to their offering.

This Optic Neuritis Pipeline Insights report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Optic Neuritis.

This report provides information on the therapeutic development based on the Optic Neuritis dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information.

The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

Key Topics Covered:

  1. Optic Neuritis Overview
  2. Optic Neuritis Pipeline Therapeutics
  3. Optic Neuritis Therapeutics under Development by Companies
  4. Optic Neuritis Late Stage Products (Filed and Phase III)
  5. Comparative Analysis
  6. Optic Neuritis Mid Clinical Stage Products (Phase II)
  7. Comparative Analysis
  8. Optic Neuritis Early Clinical Stage Products (Phase I and IND Filed)
  9. Comparative Analysis
  10. Optic Neuritis Discovery and Pre-Clinical Stage Products
  11. Comparative Analysis
  12. Drug Candidate Profiles
  13. Optic Neuritis - Therapeutics Assessment
  14. Assessment by Monotherapy Products
  15. Assessment by Combination Products
  16. Assessment by Route of Administration
  17. Assessment by Molecule Type
  18. Optic Neuritis - Discontinued Products
  19. Optic Neuritis - Dormant Products
  20. Companies Involved in Therapeutics Development for Optic Neuritis
  21. Appendix

For more information visit http://www.researchandmarkets.com/research/9tcnnj/optic

Research and MarketsLaura Wood, Senior Managerpress@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716Sector: Pharmaceuticals